Search hospitals > Georgia > Gainesville
Northeast Georgia Medical Center
Claim this profileGainesville, Georgia 30501
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
254 reported clinical trials
8 medical researchers
Summary
Northeast Georgia Medical Center is a medical facility located in Gainesville, Georgia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Northeast Georgia Medical Center is involved with conducting 254 clinical trials across 324 conditions. There are 8 research doctors associated with this hospital, such as Charles H. Nash, Pranav Kansara, MD, Habib Samady, MD, and Adnan Elhammali.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
Stage IV
PR positive
Top PIs
Charles H. NashNortheast Georgia Medical Center-Gainesville6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
19 reported clinical trials
53 drugs studied
Pranav Kansara, MDNortheast Georgia Medical Center6 years of reported clinical research
Studies Heart Failure
Studies Stroke
2 reported clinical trials
2 drugs studied
Habib Samady, MDNortheast Georgia Medical Center3 years of reported clinical research
Studies Coronary Artery Disease
Studies Atherosclerosis
3 reported clinical trials
9 drugs studied
Adnan ElhammaliNortheast Georgia Medical Center-Gainesville2 years of reported clinical research
Studies Prostate Adenocarcinoma
Studies Adenocarcinoma
1 reported clinical trial
11 drugs studied
Clinical Trials running at Northeast Georgia Medical Center
Lung Cancer
Non-Small Cell Lung Cancer
Gallbladder Cancer
Cancer
Pancreatic Cancer
Breast Cancer
Small Cell Lung Cancer
Endometrial Cancer
ALK Gene Rearrangement
Adenocarcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Ramucirumab + Pembrolizumab vs Chemotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northeast Georgia Medical Center?
Northeast Georgia Medical Center is a medical facility located in Gainesville, Georgia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Northeast Georgia Medical Center is involved with conducting 254 clinical trials across 324 conditions. There are 8 research doctors associated with this hospital, such as Charles H. Nash, Pranav Kansara, MD, Habib Samady, MD, and Adnan Elhammali.